ARA290 (Cibinetide) – 10mg (10 vials)

ARA-290 (Cibinetide) – 10mg – 10 Vials

Product Overview

ARA-290, also known as cibinetide, is a synthetic peptide based on a specific region of erythropoietin (EPO). It was developed for research into tissue-protective signaling mechanisms distinct from the red-blood-cell production activity associated with full-length EPO.

Cibinetide has attracted scientific interest for its potential interactions with cellular protection and inflammatory signaling pathways. Its research history does not establish the safety or effectiveness of every commercial product presentation.

Product Details

• Product Name: ARA-290
• Alternative Name: Cibinetide
• Listed Strength: 10mg
• Package Quantity: 10 vials
• Product Category: Synthetic Peptide
• Research Area: Tissue-protective signaling and inflammatory pathways
• Peptide Sequence: Confirm with supplier
• Manufacturer: Confirm with supplier
• Formulation: Confirm with supplier
• Storage Requirements: Follow verified manufacturer documentation

Scientific Background

Cibinetide has been investigated for its interaction with tissue-protective signaling mechanisms, including pathways associated with the innate repair receptor. Experimental research has explored its relationship with inflammatory responses and cellular protection.

These findings remain subject to the limitations of the available research. They should not be presented as proof that ARA-290 treats inflammation, nerve damage, pain, or other medical conditions.

Product Verification

Before publishing or distributing this product, confirm:

• Whether 10mg refers to each vial or the entire package
• Exact peptide sequence and chemical identity
• Manufacturer identity and product labeling
• Batch identification and available quality documentation
• Formulation and storage requirements
• Applicable regulatory status and distribution requirements

Important Safety and Regulatory Information

ARA-290 (cibinetide) is an investigational peptide. Do not present this specific vial product as an approved medicine or established treatment without appropriate regulatory evidence.

This description is for product identification and general research information only. It is not medical advice, a dosing guide, or a recommendation for human administration. Avoid unsupported therapeutic claims and verify the product’s identity and regulatory status before publication.